Press Release: Announcing the Launch of Our New Website

Hartford, Ct April 2001

Lyme Disease Foundation logo tick

April 21-23, 2001 – Hartford Marriott, Ct. 14th International Conference of Lyme Disease and other Tick-Borne Disorders. Diagnosis, Treatment, & Research.

Agenda [PDF]
Brochure 2001 [PDF]

Speaker Abstracts

Speaker abstracts Sun 4-22-2001 [PDF]
Speaker Abstracts Mon. 4-23-2001 [PDF]

Poster presentations [PDF]

Speaker provided articles

Implications of Harmful Microalgae & Heterotropic Dinoflagellates in Management of Sustainable Marine Fisheries [PDF]
Pfisteria and other Pfisteria-like dinoflagellates [PDF]
The Lurking Perils of Pfisteria [PDF]
Effect of Immunization on OspA on serologic Teats for LD [PDF]
Comparison of Immunodot and Western Blot Assay for Diagnosing Lyme Borreliosis [PDF]
Correlation of Seroreactivity w_response to antibiotics in Pediatric LD [PDF]
Pediatric Lyme Arthritis- Clinical Spectrum and outcome [PDF]
Comparative Evaluation of Adsorption with E. coli on ELISA Tests for Lyme Borreliosis [PDF]
Serial Measurement of Soluble Interleukin 2 Receptor Levels, an Early indicator of Treatment Response for LD [PDF]
Reinfection in Paediatric Lyme Borreliosis [PDF]
Frequency & Specificity of Antibodies that Crossreact w_Bb Antigens [PDF]
Use of Western Blot and Enzyme-Linked Immunosorbant Assays to assist in the Diagnosis of LD [PDF]
Selection of Animal Models [PDF]
Acquired Resistence to Bb infection in the Rabbit [PDF]
Comparison of Protection in Rabbits aganst Host-Adapted & cultivated Bb and immunity [PDF]
Immune Serum from rabbits infected w_Bb confers complete protection [PDF]
Limitations of the OspA Vaccine for Humans - a Review [PDF]
Rabbit as a Model for the study of LD pathogenesis & Immunity - A Review [PDF]
Evolution of the Serologic Response to Bb in treated Patients with culture confirmed EM [PDF]
Clinical Spectrum of Early LB in Patients with Culture Confirmed EM [PDF]
Comparison of Culture-Confirmed EM in NY & Slovenia [PDF]
LD Serology [PDF]
Effects of OspA vaccination on LD Serologic testing [PDF]
Limitations of 2-stage testing for LD [PDF]
Antigenic Conservation of an Immunodominant Invariable Region of the VlsE Lipoprotein in European Pathogenic Genospecies of Bb SL [PDF]
An Immunodominant Conseariable Domain of VlsE of Bb [PDF]
Sensitive and Specific Serodiagnosis of Lyme Disease by ELISA with a Peptide Based on an Immunodominant Conserved Region of Bb VlsE [PDF]
Epitope of Immunodominant Invariable Region of Bb VlsE in 3 Host Species [PDF]
Comparison of culture Confirmed EM in NY and Solvenia [PDF]
Temporal Correlations between Tick Abundance & Bb infected ticks & Increased LD [PDF]
Bb-Specific Immune Complexes in Acute LD [PDF]
Pesticide use by Licensed Applicators [PDF]
Impact of Controlled burn on Abundance of I.scapularis [PDF]
Infection w_ HGE, LD, Babesiosis in Ct. Mice [PDF]
Viral Infection of Neurons can Depress Neurotransmitter mRNA Levels w_out Histologic Injury [PDF]
Discovery of West NIle in Ct [PDF]
Isolation of West Nile in CT [PDF]
Serologic Diagnosis of LD using ELISA with Recombinant Antigens [PDF]
Serologic confirmation of Erlichia Equi & Bb in horses [PDF]
Evaluation of polyvalent Enzyme-linked assay incorporating p44 antigen for diagnosis of G. Ehrlichiosis in dogs and horses [PDF]
Dr Diagnosed EM & EM-like rashes following Lone Star tick-bite [PDF]
Erythema Migrans - My Point of View [PDF]
HME- epidemiological, clinical and laboratory diagnosis of a new Emergent infection in the United States [PDF]
Psychiatric & Cognitive Features of LD [PDF]
Igenex on LUAT [PDF]
LDF Educational Materials [PDF]
Spectrum of Gastrointestinal Manifestations of Children and Adolescents w_LD [PDF]

Lyme Disease Foundation Logo
The Lyme Disease Foundation, Inc. and all associates involved with the Lyme Disease Foundation (LDF) will not share any personal information provided here with Third Parties, nor will we disclose your donor status unless you affirmatively ask us to. The purpose of providing such information is to receive quarterly newsletters about the LDF and their general events. Submitting this form is giving consent for us to send you an email containing our newsletters, until such date as you request a stop, at which time we will remove all information involved with the email submitted.
chevron-down